首页> 外国专利> HIV PEPTIDES OF CONSERVED REGIONS, TAT, REV AND WEF AND ITS APPLICATION AS FOR EXAMPLE COMPONENTS OF VACCINE.

HIV PEPTIDES OF CONSERVED REGIONS, TAT, REV AND WEF AND ITS APPLICATION AS FOR EXAMPLE COMPONENTS OF VACCINE.

机译:保守区,TAT,REV和WEF的HIV肽及其作为疫苗成分的应用。

摘要

Peptide derived from the HIV-1 regulatory protein, wherein said peptide comprises at least one amino acid sequence selected from the group of amino acid sequences: in which the chain amino acids have the following meanings; Xaa in position 1 of the peptide derivative is Met, Ser, Cys or none, Xaa in position 2 is Glu, Asp, Val, Ser or none, Xaa in position 3 is Trp, Tyr or Phe, Xaa in position 4 is Val or Ile , Xaa in position 5 is Ile, or Asn, Xaa in position 6 is Pro, His or Ala, Xaa in position 7 is Arg, Asn, Ser, Lys, Glu or Asp, Xaa in position 12 is Leu, Ile or Nle, Xaa in position 15 is Gly or Pro, Xaa in position 16 is Ser, Asn or Ala, Xaa in position 17 is Gln, Lys or Thr, Xaa in position 18 is Pro or His, Xaa in position 19 is Leu, Ile or Nle Xaa in position 20 is Thr, Ala or Ile, Xaa in position 21 is Ala, Pro, Asp or Val, Xaa in position 22 is Cys or Ser, Xaa in position 23 is Thr, Asn or Ser, Xaa in position 24 is Asn, Lys, Arg, Gln, Ala Pro or Thr, the terminal ends of the sequences may be free amino or carboxyl groups, amides, acyl, acetyls or salts thereof, two or more residues of Cys residues may be part of an intracatenary or interc disulfide bridge attenuator, a bridge -S- (CH2) pS- or a bridge - (CH2) p in which p = 1-8, optionally interrupted by one or more heteroatoms such as O, N and S and / or said peptide sequences They are immobilized on a solid support.
机译:衍生自HIV-1调节蛋白的肽,其中所述肽包含至少一种选自氨基酸序列的氨基酸序列:其中链氨基酸具有以下含义;肽衍生物第1位的Xaa为Met,Ser,Cys或无,第2位的Xaa为Glu,Asp,Val,Ser或无,第3位的Xaa为Trp,Tyr或Phe,第4位的Xaa为Val或Ile,第5位的Xaa是Ile或Asn,第6位的Xaa是Pro,His或Ala,第7位的Xaa是Arg,Asn,Ser,Lys,Glu或Asp,第12位的Xaa是Leu,Ile或Nle ,第15位的Xaa是Gly或Pro,第16位的Xaa是Ser,Asn或Ala,第17位的Xaa是Gln,Lys或Thr,第18位的Xaa是Pro或His,第19位的Xaa是Leu,Ile或第20位的Nle Xaa是Thr,Ala或Ile,第21位的Xaa是Ala,Pro,Asp或Val,第22位的Xaa是Cys或Ser,第23位的Xaa是Thr,Asn或Ser,第24位的Xaa是Asn,Lys,Arg,Gln,Ala Pro或Thr,序列的末端可以是游离氨基或羧基,酰胺,酰基,乙酰基或其盐,Cys残基的两个或多个残基可以是链内或残基的一部分。 Interc二硫桥衰减器,桥-S-(CH2)pS-或桥-(CH 2)p,其中p = 1-8,任选地被一个或多个杂原子如O,N和S和/或所述肽序列中断。它们固定在固体支持物上。

著录项

  • 公开/公告号ES2296793T3

    专利类型

  • 公开/公告日2008-05-01

    原文格式PDF

  • 申请/专利权人 BIONOR IMMUNO AS;

    申请/专利号ES20010965768T

  • 发明设计人 SORENSEN BIRGER;

    申请日2001-09-03

  • 分类号C07K14/16;G01N33/569;A61K9/127;A61K39;A61K39/12;A61K39/21;A61P31/18;C07K16/08;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号